Anebulo Pharmaceuticals, Inc. SEC filings ANEB

Anebulo Pharmaceuticals, Inc. has 204 filings in SEC EDGAR's recent list, going back to Jun 25, 2020. Its latest annual report, Form 10-K, was filed on Sep 29, 2025 for the period ended Jun 30, 2025. The latest quarterly report (Form 10-Q) was filed on Feb 12, 2026, covering the quarter ended Dec 31, 2025. The most recent current report (Form 8-K) was filed on Feb 12, 2026 (results of operations). The company's fiscal year ends on June 30.

Form Description Filed Period
S-8 POS Filing Sep 26, 2025 —
S-8 POS Filing Sep 26, 2025 —
POS AM Filing Sep 19, 2025 —
POS AM Filing Sep 19, 2025 —
S-8 Employee stock plan registration May 15, 2025 —
424B5 Prospectus supplement Mar 3, 2025 —
S-3 Shelf registration Feb 20, 2025 —
S-1 Registration statement Nov 2, 2022 —
S-8 Employee stock plan registration Apr 22, 2022 —
424B4 Prospectus May 10, 2021 —
S-1/A Amended registration statement May 5, 2021 —
FWP Free writing prospectus Apr 26, 2021 —
S-1/A Amended registration statement Apr 26, 2021 —
S-1 Registration statement Apr 1, 2021 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ANEB (OTC)
Fiscal year ends
June 30
Incorporated in
DE
Headquarters
Lakeway, TX
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1815974

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.